Shopping Cart
Remove All
Your shopping cart is currently empty
RG7697 is a dual agonist for the glucagon-like peptide receptor (GLP Receptor) and the glucose-dependent insulinotropic polypeptide receptor (GIPR), with EC50 values of 5 and 3 pM, respectively. RG7697 exhibits antihyperglycemic activity.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | RG7697 is a dual agonist for the glucagon-like peptide receptor (GLP Receptor) and the glucose-dependent insulinotropic polypeptide receptor (GIPR), with EC50 values of 5 and 3 pM, respectively. RG7697 exhibits antihyperglycemic activity. |
| In vivo | RG7697 (3-30 nmol/kg, subcutaneous injection, daily for 7 days; or every other day for 30 days) enhances insulin secretion and metabolism, reduces glucose transfer, and ameliorates diet-induced type 2 diabetes and obesity in C57BL/6 mouse models. |
| Formula | C211H316N46O61 |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.